AbbVie Inc (NYSE: ABBV) announced on Friday the declaration by its board of directors of a quarterly cash dividend of USD1.07 per share.
This cash dividend is payable on 15 November 2019 to stockholders of record at the close of business on 15 October 2019.
The company added that since its inception in 2013, it has increased its dividend by 168%.
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.
Titan Pharmaceuticals announces Q2 2019 financial results
BioSpecifics Technologies reports Q2 2019 financial results
Nektar Therapeutics reports H1 2019 financial results
Medicure reports quarter ended 30 June 2019 financial results
Deciphera Pharmaceuticals' net loss narrows to USD21.5m in Q2 2019
CONMED Corporation to pay quarterly dividend of USD0.20 per share
Acerus and Aytu Bioscience to Co-promote Natesto in the United States
Amgen reports financial results for Q2 2019
Pfizer to integrate Upjohn with Mylan to establish new global pharmaceutical company